-
to outstanding facilities of Genomics, Genetics, Proteomics, Confocal and high-content imaging, Histopathology, Analytical Chemistry, Flow Cytometry, etc. The position is based in the Gliniak lab
-
directions, as well as close mentorship tailored to career goals. Additionally, this position offers access to state-of-the-art facilities and core resources (e.g., imaging, flow cytometry, proteomics), and
-
grant-funded research as directed by the PI (Dr. Zander). This research will include performing genetic, (epi)genomics and proteomic analyses in crop and medicinal plant species. It is expected
-
clinical research on pharmacology, toxicology, and exposure science. Dr. Bernstein’s research team has access to outstanding facilities of Genomics, Genetics, Proteomics, Confocal and high-content imaging
-
of the 3 areas: Proteomics, Organic/Medicinal Chemistry, and Cell Biology. Multiple training backgrounds from these areas are not required at all. Devote 40-50% research time to 1 of the 3 areas. Use 50
-
research as directed by the PI (Dr. Zander). This research will include performing genetic, (epi)genomics and proteomic analyses in hemp. It is expected that the research findings will be published, with
-
microfluidic and organ-on-a-chip technologies for new contraceptive discovery. More information about Dr. Xiao’s research can be found at https://eohsi.rutgers.edu/eohsi-directory/name/shuo-xiao